Abstract
In patients with myocarditis, early diagnosis and appropriate therapy are
mandatory, as well as close clinical follow-up with particular regard to
progression of disease and ventricular arrhythmia recurrences. The management of
ventricular arrhythmias should follow current guidelines for ICD implantation,
but new therapeutic options could be evaluated in these patients, such as
combined epicardial/endocardial ablation and external wearable defibrillator.
Particularly, depressed left ventricular ejection fraction (LVEF) represents the
only risk marker for sudden cardiac death currently used in myocarditis, although
the use of a single risk factor has limited utility. On this regard, combined
analysis of myocardial tissue structure by cardiac magnetic resonance (CMR) and
endomyocardial biopsy, in association with resting cardiac systolic function,
could improve predictive accuracy for SCD in patients with myocarditis.
Lingua originale | English |
---|---|
pagine (da-a) | 1121-1121 |
Numero di pagine | 1 |
Rivista | Journal of Atrial Fibrillation |
Volume | 7 |
DOI | |
Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- Atrial fibrillation
- Myocarditis